Erden Banoglu

17PUBLICATIONS
37CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designMolecular medicineMolecular targetsFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 03, 2026
Biotinylated Diaryl Isoxazole Derivatives with Enhanced Janus Kinase 1 Inhibitory, Antiproliferative, and Apoptotic Activities in Cancer Cells.

|Jan 16, 2025
2-Phenylbenzothiazoles featuring heteroaryl sulfonamide end-capping substructures as developable mPGES-1 inhibitors.

Tansu Yalçın, Paul M Jordan, Abdurrahman Olğaç

|Dec 02, 2024
Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever.

Azize Gizem Ergül, Paul M Jordan, Philipp Dahlke

|Feb 06, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer

|Sep 04, 2023
Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein.

Abdurrahman Olğaç, İrfan Çapan, Philipp Dahlke

|Jan 23, 2023
Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors.

Tugce Gur Maz, Beyzanur Koc, Paul M Jordan

Pageof 3

Frequent Collaborators

8 joint publications

Burcu Çalışkan

7 joint publications

Oliver Werz

4 joint publications

Kübra Ibis

4 joint publications

Tuğçe Gür Maz